Tag : Bio

Latest News

Aurora Bio, Inc Announces Clinical Data on Lead Program, AUR01, a Novel Systemic Amyloidosis Imaging Tracer, at the Upcoming 61st American Society of Hematology Annual Meeting and Exposition

Newsemia
ORLANDO, Fla.–(BUSINESS WIRE)–Aurora Bio, Inc www.Aurorabioinc.com today announced data for the company’s novel PET radiotracer, AUR01, in development for systemic amyloidosis, was presented by Dr....
Latest News

GVK BIO annonce la promotion de Sudhir Kumar Singh au poste de directeur des opérations et la nomination de Ramesh Subramanian en tant que nouveau directeur commercial de GVK BIO

Newsemia
HYDERABAD, Inde–(BUSINESS WIRE)–GVK BIO, une importante organisation de recherche et développement sous contrat (Contract Research and Development Organisation, CRDO), a le plaisir d’annoncer la promotion...
Latest News

CORRECTING and REPLACING Civilization Ventures Announces Portfolio Exit with Acquisition of Singular Bio by Invitae (NYSE: NVTA)

Newsemia
SAN FRANCISCO–(BUSINESS WIRE)–<a href="https://twitter.com/search?q=%24NVTA&src=ctag" target="_blank">$NVTA</a> <a href="https://twitter.com/hashtag/diagnostics?src=hash" target="_blank">#diagnostics</a>–In the headline, and in the first sentence of the release, “(NASDAQ: NVTA)” should instead read “(NYSE: NVTA)”...
Biology

IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases

Newsemia
NEW YORK and SOMERSET, N.J. (PRWEB) June 17, 2019 IVERIC bio, Inc. (NASDAQ: ISEE) and Catalent Biologics, today announced that they have entered into an...
Latest News

Sesen Bio to Host Conference Call to Review First Quarter 2019 Financial Results and Updated Preliminary Data from Phase 3 VISTA Trial

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sesen Bio (Nasdaq:SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that Company...
Biology

ASGCT Members Elect Five New Directors from CHOP, UMass, Advanced Therapy Partners, bluebird bio, and Vanderbilt University

Newsemia
MILWAUKEE (PRWEB) April 09, 2019 The American Society of Gene & Cell Therapy (ASGCT) is excited to welcome five incoming members of the Society's leadership...
Latest News

Thermo Fisher to buy gene therapy contract manufacturer Brammer Bio for $1.7B

Newsemia
Brammer specializes in contract services for viral vector-based gene therapies. Panelists at a conference last week stressed the importance of manufacturing for gene therapy investors....

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy